← SynDRA
PEVONEDISTAT
SynDRA canonical compound SYN0024188 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | NAE1 | UBA3 |
| Mechanism of action | nedd activating enzyme inhibitor |
All known targets
- NAE1
- UBA3
- NAE1; UBA3
- NEDD8
Mechanisms of action (all sources)
- UBA3 INHIBITOR
- NEDD8 activating enzyme inhibitor
- NAE1 INHIBITOR
- nedd activating enzyme inhibitor
- Modulator
- NEDD8 INHIBITOR
Drug classes
Cross-references
Synonyms
- MLN-4924
- MLN-4924003
- MLN4924
- PEVONEDISTAT (MLN4924)
- UNII-S3AZD8D215
- MLN 4924
- S3AZD8D215
- Sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl ester
- ((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate
- C21H25N5O4S
- [(1s,2s,4r)-4-{4-[(1s)-2,3-Dihydro-1h-Inden-1-Ylamino]-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl}-2-Hydroxycyclopentyl]methyl Sulfamate
- Pevonedistat [USAN:INN]
- 3gzn
- Pevonedistat (MLN-4924)
- 905579-51-3 (free base)
- Pevonedistat (USAN)
- PEVONEDISTAT [USAN]
- ((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate
- Sulfamic acid, ((1S,2S,4R)-4-(4-(((1S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl ester
- pevonedistatum
- ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
- B39
- Pevonedistat; MLN4924
- PEVONEDISTAT [INN]
- ((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulphamate
- MLS006010830
- PEVONEDISTAT [WHO-DD]
- SCHEMBL192875
- TAK924
- CHEMBL1231160
- CHEBI:95028
- GTPL12117
- TAK-924
- CHEBI:145535
- DTXSID701022549
- EX-A1472
- BDBM50285607
- NSC793435
Look up PEVONEDISTAT in the interactive SynDRA portal →